Eileen M. O’Reilly

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.6Author DataRank

Indexed papers

6in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 6 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomes

Cancer(2021)10.1002/cncr.33812

Top 17%

1.2DataRank

Top 17%42 citations

Catherine O’Connor, Joanne F. Chou, Marinela Capanu, Wungki Park, Chaitanya Bandlamudi +19 more

Papers

Driven by 94 papers — median percentile 11. Top paper: “Preoperative Treatment of Locally Advanced Rectal Cancer”.

Preoperative Treatment of Locally Advanced Rectal Cancer

New England Journal of Medicine(2023)10.1056/nejmoa2303269

N/A

5.6DataRank · unranked

460 citations

Qian Shi, Martin R. Weiser, Marc J. Gollub, Leonard B. Saltz, Benjamin Musher +20 more

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial

The Lancet(2023)10.1016/s0140-6736(23)01366-1

N/A

5.4DataRank · unranked

454 citations

Davide Melisi, Teresa Macarulla, Roberto Pazo-Cid, Sreenivasa R Chandana, Christelle de la Fouchardière +14 more

Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer

Journal of Clinical Oncology(2022)10.1200/jco.21.01604

N/A

4.0DataRank · unranked

230 citations

Pascal Hammel, Michele Reni, Eric Van Cutsem, Teresa Macarulla, Michael J. Hall +14 more

Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors

New England Journal of Medicine(2024)10.1056/nejmoa2403991

N/A

3.0DataRank · unranked

141 citations

Susan M. Geyer, Tyler Zemla, Michael V. Knopp, Spencer C. Behr, Sydney Pulsipher +19 more

Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancer

Nature Medicine(2024)10.1038/s41591-024-03075-7

N/A

2.2DataRank · unranked

57 citations

Constantinos P. Zambirinis, Jonathan M. Hernandez, Jayasree Chakraborty, Lee Shaashua, Junbum Kim +71 more

Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomes

Cancer(2021)10.1002/cncr.33812

Top 17%

1.2DataRank

Top 17%42 citations

Catherine O’Connor, Joanne F. Chou, Marinela Capanu, Wungki Park, Chaitanya Bandlamudi +19 more

Improved Survival With Adjuvant Cyclooxygenase 2 Inhibition in PIK3CA-Activated Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance)

Journal of Clinical Oncology(2024)10.1200/jco.23.01680

N/A

0.944DataRank · unranked

25 citations

Tyler S. Twombly, Chao Ma, Qian Shi, Koichiro Haruki, Kenji Fujiyoshi +17 more

Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer

BMC Cancer(2024)10.1186/s12885-024-12529-7

N/A

0.808DataRank · unranked

39 citations

Qian Shi, Arvind Dasari, Julio García‐Aguilar, Hanna Sanoff, Thomas J. George +25 more

Postoperative Adverse Events Following Neoadjuvant Therapy and Surgery for Borderline Resectable Pancreatic Cancer in a Phase 2 Clinical Trial (Alliance A021501)

Annals of Surgical Oncology(2024)10.1245/s10434-024-15670-6

N/A

0.381DataRank · unranked

6 citations

Tyler Zemla, Qian Shi, Diana Segovia, Syed A. Ahmad, Eileen M. O’Reilly +3 more

Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: a pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur)

BMC Cancer(2024)10.1186/s12885-024-11899-2

N/A

0.324DataRank · unranked

4 citations

Eric D. Miller, Qian Shi, Jesse G. Dixon, Sepideh Gholami, Sarah B. White +13 more

KRAS Variants Are Associated With Survival Outcomes and Genomic Alterations in Biliary Tract Cancers

JCO Precision Oncology(2024)10.1200/po.24.00263

N/A

0.293DataRank · unranked

5 citations

Aistė Gulla, Hannah L. Kalvin, Yi Song, James J. Harding, Ghassan K. Abou‐Alfa +12 more

Inflammation, physical activity, and disease-free survival in stage III colon cancer: Cancer and Leukemia Group B–Southwest Oncology Group 80702 (Alliance)

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae203

Top 61%

0.241DataRank

Top 61%4 citations

Chao Ma, Qian Shi, Félix Couture, Philip Kuebler, Pankaj Kumar +8 more

Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial

Research Square(2025)10.21203/rs.3.rs-7334701/v1

N/A

0.214DataRank · unranked

3 citations

Catherine O’Connor, Joanne F. Chou, Marc Hilmi, Zeynep Tarcan, Carly Schwartz +61 more

Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer

Cancer Research(2025)10.1158/0008-5472.can-25-1117

N/A

0.172DataRank · unranked

2 citations

Sitara Persad, Akimasa Hayashi, Shigeaki Umeda, Roshan Sharma, Yubin Xie +14 more

Influence of biologic sex and obesity on liver recurrence and survival in patients undergoing upfront surgery for pancreatic adenocarcinoma

Cancer(2025)10.1002/cncr.70088

Top 78%

0.104DataRank

Top 78%1 citations

Emily Manin, Joanne Chou, Robert J. Torphy, Caitlin A. McIntyre, Vinod P. Balachandran +11 more

Radiomic signatures to predict survival in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib +/- doxorubicin: Correlative science from CALGB 80802 (Alliance).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.343

N/A

0DataRank · unranked

1 citations

Susan M. Geyer, Andrew B. Nixon, Federico Innocenti, Qian Shi, Sawyer Jacobson +12 more

Baseline level and early on-treatment clearance of circulating mutant KRAS in metastatic pancreatic ductal adenocarcinoma treated with chemotherapy with or without immunotherapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4122

N/A

0DataRank · unranked

1 citations

Aseel Abdalla, Neha Bhagwat, Taylor A. Black, Zhuoyang Wang, Stephanie S. Yee +15 more

Prognostic value of tumor deposits in stage III colon cancer patients, a post-hoc analysis of CALGB/SWOG 80702 phase III study.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.10

N/A

0DataRank · unranked

0 citations

Qian Shi, Jeffrey P. Meyers, Zhaohui Jin, Magali Svrcek, Charles S. Fuchs +14 more

Discordance between central versus local response assessments in neuroendocrine tumor (NET) patients (pts) enrolled in A021202.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.361

Top 100%

0DataRank

Top 100%0 citations

Michelle R. Mahoney, Timothy R. Asmis, Nathan C. Hall, Sanja Karovic, Michael V. Knopp +9 more

Dietary fat in relation to overall and progression-free survival among patients (pts) with advanced or metastatic colorectal cancer (CRC): Data from CALGB 80405 (Alliance).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.3588

N/A

0DataRank · unranked

0 citations

Chao Ma, Fang‐Shu Ou, Alan P. Venook, Kimmie Ng, Donna Niedzwiecki +12 more

Influence of dietary insulin scores on survival in patients with metastatic colorectal cancer (mCRC): Findings from CALGB (Alliance) 80405.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.3568

N/A

0DataRank · unranked

0 citations

Chao Ma, Fang‐Shu Ou, Chen Yuan, Brendan J. Guercio, Vicente Morales‐Oyarvide +15 more

Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

Cell(2022)10.1016/j.cell.2022.01.003

N/A

0DataRank · unranked

652 citations

Christopher J. Fong, Anisha Luthra, Shaleigh Smith, Renzo G. DiNatale, Subhiksha Nandakumar +70 more

Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene Rearrangements

Cancer Discovery(2022)10.1158/2159-8290.cd-21-1119

N/A

0DataRank · unranked

168 citations

Igor Odintsov, Madelyn Espinosa-Cotton, Inna Khodos, Whitney J. Sisso, Marissa S. Mattar +17 more

Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing

Annals of Oncology(2022)10.1016/j.annonc.2022.01.006

N/A

0DataRank · unranked

55 citations

Fresia Pareja, David N. Brown, Ozge Ceyhan‐Birsoy, Maksym Misyura, Satshil Rana +16 more

Clinico-genomic Characterization of ATM and HRD in Pancreas Cancer: Application for Practice

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1483

N/A

0DataRank · unranked

37 citations

Catherine O’Connor, Chaitanya Bandlamudi, Daniella Forman, Joanne F. Chou, Shigeaki Umeda +11 more

Stereotactic ablative radiation for pancreatic cancer on a 1.5 Telsa magnetic resonance-linac system

Physics and Imaging in Radiation Oncology(2022)10.1016/j.phro.2022.10.003

N/A

0DataRank · unranked

33 citations

Neelam Tyagi, Marsha Reyngold, Paul B. Romesser, Abraham J. Wu, Eileen M. O’Reilly +7 more

Immunogenomic characterization of biliary tract cancers: Biomarker enrichment for benefit to immune checkpoint blockade.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4083

N/A

0DataRank · unranked

3 citations

Fergus Keane, Chaitanya Bandlamudi, Mark T.A. Donoghue, Paulino Tallón de Lara, James J. Harding +15 more

Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer

Nature(2023)10.1038/s41586-023-06063-y

N/A

0DataRank · unranked

1289 citations

Zachary Sethna, Kevin C. Soares, Cristina Olcese, Nan Pang, Erin Patterson +46 more

Genomic Profiling Reveals Germline Predisposition and Homologous Recombination Deficiency in Pancreatic Acinar Cell Carcinoma

Journal of Clinical Oncology(2023)10.1200/jco.23.00561

N/A

0DataRank · unranked

44 citations

Antonio Marra, Binbin Zheng-Lin, Pier Selenica, Juan Blanco-Heredia, Yingjie Zhu +30 more

Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade

Nature Medicine(2023)10.1038/s41591-023-02544-9

N/A

0DataRank · unranked

38 citations

Michael B. Foote, Benoı̂t Rousseau, Henry Walch, Yelena Kemel, Allison L. Richards +33 more

LBA53 Alliance A021602: Phase III, double-blinded study of cabozantinib versus placebo for advanced neuroendocrine tumors (NET) after progression on prior therapy (CABINET)

Annals of Oncology(2023)10.1016/j.annonc.2023.10.047

N/A

0DataRank · unranked

27 citations

Susan M. Geyer, F-S. Ou, Michael V. Knopp, Spencer C. Behr, Tyler Zemla +14 more

Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0447

N/A

0DataRank · unranked

10 citations

Chao Ma, Chen Yuan, Qian Shi, Brian M. Wolpin, Yin Zhang +19 more

Association between physical activity and the time course of cancer recurrence in stage III colon cancer

British Journal of Sports Medicine(2023)10.1136/bjsports-2022-106445

N/A

0DataRank · unranked

26 citations

Chao Ma, Qian Shi, Donna Niedzwiecki, Tyler Zemla, Félix Couture +9 more

Dramatic, durable response to therapy in gBRCA2-mutated pancreas neuroendocrine carcinoma: opportunity and challenge

npj Precision Oncology(2023)10.1038/s41698-023-00376-x

N/A

0DataRank · unranked

6 citations

Raazi Bajwa, Pier Selenica, Wungki Park, Michael H. A. Roehrl, Jorge S. Reis‐Filho +3 more

Registration-based biomarkers for neoadjuvant treatment response of pancreatic cancer via longitudinal image registration

Journal of Medical Imaging(2023)10.1117/1.jmi.10.3.036002

N/A

0DataRank · unranked

6 citations

Brett L. Ecker, Liana Langdon‐Embry, Eileen M. O’Reilly, Michael I. Miga, William R. Jarnagin +5 more

Physical activity in recurrent colon cancer: Cancer and Leukemia Group B/SWOG 80702 (Alliance)

Cancer(2023)10.1002/cncr.35007

N/A

0DataRank · unranked

4 citations

Chao Ma, Qian Shi, Tyler Zemla, Félix Couture, Philip Kuebler +11 more

Metastatic well differentiated serotonin-producing pancreatic neuroendocrine tumor with carcinoid heart disease: a case report

Journal of Gastrointestinal Oncology(2023)10.21037/jgo-22-909

N/A

0DataRank · unranked

2 citations

Ghassan K. Abou‐Alfa, Eileen M. O’Reilly, Michael B. Foote, Bhawna Sirohi, Rawad Elias +6 more

Alliance A022104/NRG-GI010: A randomized phase II trial testing the efficacy of triplet versus doublet chemotherapy to achieve clinical complete response in patients with locally advanced rectal cancer—The Janus Rectal Cancer trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps3640

N/A

0DataRank · unranked

21 citations

Arvind Dasari, Qian Shi, Julio García‐Aguilar, Hanna K. Sanoff, Thomas J. George +13 more

Phase 2 trial of pembrolizumab and olaparib (POLAR) maintenance for patients (pts) with metastatic pancreatic cancer (mPDAC): Two cohorts B non-core homologous recombination deficiency (HRD) and C exceptional response to platinum-therapy.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.4140

N/A

0DataRank · unranked

19 citations

Catherine O’Connor, Joanne F. Chou, Carly Schwartz, Anna M. Varghese, Mary Pat Larsen +15 more

PROSPECT: A randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total mesorectal excision (TME) for treatment of locally advanced rectal cancer (LARC) (Alliance N1048).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.17_suppl.lba2

N/A

0DataRank · unranked

18 citations

Qian Shi, Martin R. Weiser, Marc J. Gollub, Leonard B. Saltz, Benjamin Musher +15 more

APOLLO: A randomized phase II double-blind study of olaparib versus placebo following curative intent therapy in patients with resected pancreatic cancer and a pathogenic BRCA1, BRCA2 or PALB2 mutation—ECOG-ACRIN EA2192.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps763

N/A

0DataRank · unranked

8 citations

Sung Chul Hong, Anup Kasi, Eileen M. O’Reilly, Shishir K. Maithel, Xin Yao +10 more

Randomized phase II trial of olaparib + pembrolizumab vs olaparib alone as maintenance therapy in metastatic pancreatic cancer patients with germline BRCA1 or BRCA2 (gBRCA1/2+) pathogenic variants: SWOG S2001.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps4198

N/A

0DataRank · unranked

6 citations

Katherine A. Guthrie, Michael J. Pishvaian, Kim Anna Reiss, Andrew M. Lowy, Davendra Sohal +7 more

A randomized trial of consolidation-targeted adjuvant therapy with encorafenib and cetuximab versus usual care for patients with stage II/III BRAF V600E colon cancer: Alliance for Clinical Trials in Oncology A022004.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps3641

N/A

0DataRank · unranked

6 citations

Qian Shi, Amylou C. Dueck, Elie G. Dib, Syed Mohammad Ali Kazmi, Olatunji B. Alese +6 more

Alliance A021804: A prospective, multi-institutional phase II trial evaluating temozolomide versus temozolomide and olaparib for advanced pheochromocytoma and paraganglioma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps4191

N/A

0DataRank · unranked

5 citations

Kimberly Perez, Susan M. Geyer, Maged Khalil, Aishwarya Vijendran, Andrea Kordaris-Corkill +9 more

Apollo: A randomized phase II double-blind study of olaparib versus placebo following curative intent therapy in patients with resected pancreatic cancer and a pathogenic BRCA1, BRCA2, or PALB2 mutation—ECOG-ACRIN EA2192.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps4202

N/A

0DataRank · unranked

3 citations

Sung Chul Hong, Anup Kasi, Eileen M. O’Reilly, Shishir K. Maithel, Xin Yao +10 more

Alliance A022101: A pragmatic, randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: Evaluating Radiation, Ablation, and Surgery (ERASur).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps3629

N/A

0DataRank · unranked

1 citations

Paul B. Romesser, Qian Shi, Jesse G. Dixon, Sepideh Gholami, Sarah B. White +12 more

Alliance for Clinical Trials in Oncology (Alliance) trial A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur)

Research Square(2023)10.21203/rs.3.rs-3773522/v1

N/A

0DataRank · unranked

1 citations

Eric D. Miller, Qian Shi, Jesse G. Dixon, Sepideh Gholami, Sarah B. White +13 more

Data from Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance)

(2023)10.1158/1078-0432.c.6531153

Top 100%

0DataRank

Top 100%0 citations

Alexander B. Sibley, Yingmiao Liu, Ace J. Hatch, Chen Jiang, Flora Mulkey +13 more

Data from Clinico-genomic Characterization of ATM and HRD in Pancreas Cancer: Application for Practice

(2023)10.1158/1078-0432.c.6532713.v1

Top 100%

0DataRank

Top 100%0 citations

Catherine O’Connor, Chaitanya Bandlamudi, Daniella Forman, Joanne F. Chou, Shigeaki Umeda +11 more

Alliance A022102: Randomized phase III trial of mFOLFIRINOX +/- nivolumab vs. FOLFOX +/- nivolumab for first-line treatment of metastatic HER2-negative gastroesophageal adenocarcinoma (GEA).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps4175

N/A

0DataRank · unranked

0 citations

Susan M. Geyer, Kelsey Klute, Jonathan Bleeker, Daniel A. King, Matthew R. Strickland +7 more

P-190 NALIRIFOX (iposomal irinotecan + 5-fluorouracil/feucovorin + oxaliplatin) versus FOLFOX [5-fluorouracil/leucovorin + oxaliplatin] as first-line treatment of metastatic pancreatic ductal adenocarcinoma (mPDAC): Real-world comparative overall survival

Annals of Oncology(2023)10.1016/j.annonc.2023.04.246

N/A

0DataRank · unranked

0 citations

Jiaqi Li, Maral DerSarkissian, R. Chang, Meng-Fu Cheng, Yu Liu +7 more

Targeting KRAS in cancer

Nature Medicine(2024)10.1038/s41591-024-02903-0

N/A

0DataRank · unranked

287 citations

Bob T. Li, Eileen M. O’Reilly, Anupriya Singhal

Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer

Cancer Cell(2024)10.1016/j.ccell.2024.08.002

N/A

0DataRank · unranked

66 citations

Adrien Grimont, Jiwoon Park, Yinuo Meng, Whitney J. Sisso, Kenneth Seier +26 more

Next-generation therapies for pancreatic cancer

Expert Review of Gastroenterology & Hepatology(2024)10.1080/17474124.2024.2322648

N/A

0DataRank · unranked

43 citations

Eileen M. O’Reilly, Conor Buckley

SWI/SNF Complex-Deficient Undifferentiated Carcinoma of the Pancreas: Clinicopathologic and Genomic Analysis

Modern Pathology(2024)10.1016/j.modpat.2024.100585

N/A

0DataRank · unranked

17 citations

Kerem Özcan, Volkan Adsay, Serdar Balcı, Zeynep Tarcan, Jaclyn F. Hechtman +18 more

Plant-based diet and survival among patients with metastatic colorectal cancer

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae213

N/A

0DataRank · unranked

15 citations

Fang‐Shu Ou, Clare A. Gatten, Chao Ma, Alan P. Venook, Heinz‐Josef Lenz +8 more

Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma

Nature Communications(2024)10.1038/s41467-024-49915-5

N/A

0DataRank · unranked

13 citations

Lee McDaniel, Changgee Chang, Qi Long, Shannon M. Pfeiffer, Jaclyn P. Lyman +37 more

Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae095

N/A

0DataRank · unranked

11 citations

Joanne F. Chou, Henry Walch, Joshua D. Schoenfeld, Anupriya Singhal, Darren Cowzer +12 more

Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapy

The Oncologist(2024)10.1093/oncolo/oyae110

N/A

0DataRank · unranked

5 citations

Joanne F. Chou, Henry Walch, Fergus Keane, Danny N. Khalil, Jinru Shia +20 more

Extrahepatic Cholangiocarcinoma: Genomic Variables Associated With Anatomic Location and Outcome

JCO Precision Oncology(2024)10.1200/po.24.00206

N/A

0DataRank · unranked

9 citations

Esther Drill, Thomas Boerner, Rebecca Gelfer, James J. Harding, Eileen M. O’Reilly +11 more

Salvage Ablative Radiotherapy for Isolated Local Recurrence of Pancreatic Adenocarcinoma following Definitive Surgery

Journal of Clinical Medicine(2024)10.3390/jcm13092631

N/A

0DataRank · unranked

3 citations

Victor Ng, Eileen M. O’Reilly, Alice C. Wei, Stephanie Lobaugh, Anna M. Varghese +14 more

Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohort

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae269

N/A

0DataRank · unranked

3 citations

Catherine O’Connor, Drew Moss, Joanne F. Chou, Maria Perry, Fionnuala Crowley +26 more

Has Management of Intrahepatic Cholangiocarcinoma Evolved with the Evidence? Trends and Practice Patterns from the National Cancer Database

Annals of Surgical Oncology(2024)10.1245/s10434-024-15724-9

N/A

0DataRank · unranked

4 citations

Hannah L. Kalvin, Ryan J. Ellis, T. Peter Kingham, Kevin C. Soares, Michael I. D’Angelica +10 more

CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma

Cancer Research Communications(2024)10.1158/2767-9764.crc-22-0516

N/A

0DataRank · unranked

2 citations

Susan M. Geyer, Andrew B. Nixon, Federico Innocenti, Qian Shi, Priya Kumthekar +16 more

Concordance in Oncogenic Alterations Between the Primary Tumor and Advanced Disease: Insights Into the Heterogeneity of Intrahepatic Cholangiocarcinoma

JCO Precision Oncology(2024)10.1200/po.23.00534

N/A

0DataRank · unranked

3 citations

William Preston, Henry Walch, Jeremy Sharib, Ritika Kundra, Carlie Sigel +18 more

Controversies in upper GI oncology: maintenance treatment in pancreatic cancer

ESMO Open(2024)10.1016/j.esmoop.2024.102244

N/A

0DataRank · unranked

0 citations

Daniel A. Laheru, Eileen M. O’Reilly, Jeroen Dekervel

Alliance A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer—Evaluating radiation, ablation, and surgery (ERASur).

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.tps3633

N/A

0DataRank · unranked

0 citations

Kathryn Hitchcock, Qian Shi, Jesse G. Dixon, Sepideh Gholami, Sarah B. White +12 more

Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival

Nature Medicine(2025)10.1038/s41591-024-03362-3

N/A

0DataRank · unranked

75 citations

Maria Perry, Joanne F. Chou, Subhiksha Nandakumar, Daniel M. Muldoon, Amanda Erakky +24 more

Utilizing Patient Input in Rectal Cancer Trial Design

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf074

N/A

0DataRank · unranked

4 citations

Wini Zambare, Manju George, Reese Garcia, Phuong Gallagher, Caleah Kitchens +22 more

Clinical utility and tissue concordance of circulating tumor DNA in pancreatic ductal adenocarcinoma

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf139

N/A

0DataRank · unranked

4 citations

Lily V. Saadat, Catherine O’Connor, Joanne F. Chou, Anita S. Bowman, Fei Xu +18 more

Sex differences in chemotherapy completion, toxicities, and survival in colon cancer: an analysis of 2201 patients from CALGB/SWOG 80702 (Alliance)

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf281

N/A

0DataRank · unranked

4 citations

Qian Shi, Anthony F. Shields, Xiaonan Xue, Thomas E. Rohan, Chaoyuan Kuang +12 more

1712P Efficacy and safety of cabozantinib (CABO) for advanced lung and thymic neuroendocrine tumors (NET) after progression on prior therapy: Subgroup analysis of phase III CABINET Trial (Alliance A021602)

Annals of Oncology(2025)10.1016/j.annonc.2025.08.2340

N/A

0DataRank · unranked

1 citations

T. Zemla, Susan M. Geyer, Jonathan Strosberg, Þorvarður R. Hálfdánarson, Nikolaos A. Trikalinos +13 more

350P IDH2-mutated cholangiocarcinoma: A case series highlighting challenges and insights

Annals of Oncology(2025)10.1016/j.annonc.2025.05.365

N/A

0DataRank · unranked

1 citations

James J. Harding, Rohit Thummalapalli, D. Khalil, Amin Yaqubie, Eileen M. O’Reilly +2 more

Radiomic signatures to estimate survival in patients with advanced hepatocellular carcinoma treated with sorafenib: Cancer and Leukemia Group B 80802 (Alliance)

ESMO Open(2025)10.1016/j.esmoop.2025.105848

N/A

0DataRank · unranked

1 citations

Susan M. Geyer, Andrew B. Nixon, Federico Innocenti, Q. Shi, Steven Jacobson +15 more

Alliance A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer—Evaluating radiation, ablation, and surgery (ERASur).

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.tps3634

N/A

0DataRank · unranked

0 citations

Kathryn Hitchcock, Qian Shi, Jesse G. Dixon, Sepideh Gholami, Sarah B. White +12 more

Trials in progress: Alliance A022104/NRG-GI010—A randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer (LARC; the Janus Rectal Cancer trial).

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.tps3650

N/A

0DataRank · unranked

0 citations

Qian Shi, Arvind Dasari, Julio García‐Aguilar, Hanna K. Sanoff, Thomas J. George +15 more

ASO Visual Abstract: Survival Outcomes and Genetic Characteristics of Resected Pancreatic Acinar Cell Carcinoma

Annals of Surgical Oncology(2025)10.1245/s10434-024-16439-7

N/A

0DataRank · unranked

0 citations

Shannon N. Radomski, Joanne F. Chou, Mengyuan Liu, Thomas Clark Howell, Wungki Park +18 more

343P Body mass index and somatic variants in biliary tract cancers

Annals of Oncology(2025)10.1016/j.annonc.2025.05.358

N/A

0DataRank · unranked

0 citations

Joanne Chou, M. Capanu, Amitabh Srivastava, C. Sigel, Rayan Alsuwailem +6 more

Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0418

N/A

0DataRank · unranked

227 citations

Jiapeng Chen, Joanne F. Chou, Anna M. Varghese, Kenneth H. Yu, Winston Wong +26 more

Intrahepatic Cholangiocarcinoma: Recurrence Patterns, Genomics, and Survival

JCO Precision Oncology(2025)10.1200/po-25-00402

N/A

0DataRank · unranked

0 citations

Yi Song, Esther Drill, Alice C. Wei, Nancy E. Kemeny, Andrea Cercek +13 more

The Evolutionary Origins of Recurrent Pancreatic Cancer

Cancer Discovery(2020)10.1158/2159-8290.cd-19-1508

N/A

0DataRank · unranked

131 citations

Marc A. Attiyeh, Jeffrey M. Gerold, Alvin P. Makohon-Moore, Akimasa Hayashi, Jungeui Hong +17 more

Body Mass Index and Weight Loss in Metastatic Colorectal Cancer in CALGB (Alliance)/SWOG 80405

JNCI Cancer Spectrum(2020)10.1093/jncics/pkaa024

N/A

0DataRank · unranked

13 citations

Sui Zhang, Alan P. Venook, Fang‐Shu Ou, Donna Niedzwiecki, Heinz‐Josef Lenz +15 more

IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405

JNCI Cancer Spectrum(2020)10.1093/jncics/pkaa074

N/A

0DataRank · unranked

9 citations

Sui Zhang, Fang‐Shu Ou, Alan P. Venook, Donna Niedzwiecki, Heinz‐Josef Lenz +17 more

Landscape of DNA-damage-repair/homologous recombination deficiency (DDR/HRD) in hepatopancreaticobiliary (HPB) cancers.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4620

N/A

0DataRank · unranked

4 citations

Ethan Sokol, Jiapeng Chen, Kenneth H. Yu, Danny N. Khalil, James J. Harding +7 more

Pharmacogenomic blood-based assay to predict chemotherapy response and survival in pancreatic cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.738

N/A

0DataRank · unranked

1 citations

Brian P. McCarthy, William H. Isacoff, Brandon Cooper, Andrew A. Bartlett, Jennifer Park +4 more

25-Hydroxyvitamin D Levels and Survival in Advanced Pancreatic Cancer: Findings From CALGB 80303 (Alliance)

UNC Libraries(2020)10.17615/qen9-yc42

N/A

0DataRank · unranked

0 citations

Donna Niedzwiecki, Chen Jiang, Eileen M. O’Reilly, Kouros Owzar, Hedy L. Kindler +5 more

Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS

Nature Communications(2021)10.1038/s41467-021-24109-5

N/A

0DataRank · unranked

183 citations

Gowtham Jayakumaran, Monica Diosdado, Juber Patel, Anna Razumova, Yu Hu +64 more

Survival in Young-Onset Metastatic Colorectal Cancer: Findings From Cancer and Leukemia Group B (Alliance)/SWOG 80405

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab200

N/A

0DataRank · unranked

45 citations

Sui Zhang, Fang‐Shu Ou, Chao Ma, Nadine J. McCleary, Donna Niedzwiecki +16 more

Treatment patterns and survival in patients with early‐onset pancreatic cancer

Cancer(2021)10.1002/cncr.33664

N/A

0DataRank · unranked

42 citations

Joanne F. Chou, Mithat Gönen, Kevin C. Soares, T. Peter Kingham, Anna M. Varghese +6 more

Pharmacologically controlling protein-protein interactions through epichaperomes for therapeutic vulnerability in cancer

Communications Biology(2021)10.1038/s42003-021-02842-3

N/A

0DataRank · unranked

26 citations

Erica DaGama Gomes, Tai Wang, Adriana Corben, Tony Taldone, Srinivasa Gandu +35 more

Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance)

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2389

N/A

0DataRank · unranked

20 citations

Alexander B. Sibley, Yingmiao Liu, Ace J. Hatch, Chen Jiang, Flora Mulkey +13 more

Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy (RT) for borderline resectable (BR) adenocarcinoma of the pancreas.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.377

N/A

0DataRank · unranked

144 citations

Qian Shi, Jeffrey P. Meyers, Joseph M. Herman, Michael Choung, Brian M. Wolpin +13 more

Randomized phase II trial of olaparib + pembrolizumab versus olaparib alone as maintenance therapy in metastatic pancreatic cancer patients with germline BRCA1 or BRCA2 (gBRCA1/2+) mutations: SWOG S2001.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.tps447

N/A

0DataRank · unranked

13 citations

Katherine A. Guthrie, Michael J. Pishvaian, Andrew M. Lowy, E. Gabriela Chiorean, Mai T. Duong +3 more

Alliance/CALGB 80802: Impact of hepatitis C (HCV) on doxorubicin (DO) + sorafenib (S) versus S in patients (pts) with advanced hepatocellular carcinoma (aHCC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.325

N/A

0DataRank · unranked

2 citations

Susan M. Geyer, Andrew B. Nixon, Federico Innocenti, Qian Shi, Sawyer Jacobson +12 more

Eileen M. O’Reilly

Indexed papers

Top data-sharing exemplar

Papers